Edmond de Rothschild Holding’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-184,060
Closed -$6.65M 739
2023
Q2
$6.65M Hold
184,060
0.13% 147
2023
Q1
$6.84M Buy
184,060
+15,000
+9% +$558K 0.16% 141
2022
Q4
$7.66M Buy
169,060
+10,000
+6% +$453K 0.18% 130
2022
Q3
$11.1M Hold
159,060
0.29% 100
2022
Q2
$10.7M Buy
159,060
+6,000
+4% +$403K 0.26% 115
2022
Q1
$12.6M Buy
153,060
+63,060
+70% +$5.18M 0.27% 104
2021
Q4
$13.2M Buy
90,000
+5,780
+7% +$848K 0.29% 99
2021
Q3
$14.9M Buy
84,220
+13,960
+20% +$2.47M 0.34% 78
2021
Q2
$11.3M Buy
70,260
+21,900
+45% +$3.54M 0.26% 102
2021
Q1
$8.28M Buy
48,360
+7,150
+17% +$1.22M 0.23% 120
2020
Q4
$9.05M Sell
41,210
-17,290
-30% -$3.8M 0.3% 98
2020
Q3
$9.71M Hold
58,500
0.38% 77
2020
Q2
$6.68M Buy
58,500
+33,000
+129% +$3.77M 0.27% 102
2020
Q1
$1.96M Buy
+25,500
New +$1.96M 0.1% 167